Bio-engineered Stent Market - Global Industry Insights and Forecast to 2026

1. Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

2. BIO-ENGINEERED STENT MARKET ANALYSIS • Bio-engineered Stent Market, by Application Type (Coronary Artery Disease, Peripheral Arterial Disease, Carotid Artery Disease, Renal Artery Stenosis, Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm, Others), by Product Type (Drug-eluting Stents, Bioabsorbable Stents, and Drug-eluting Balloons), by Mode of Delivery (Balloon-expandable Stents and Self-expanding Stents), by Material Type (Metal-based and Polymer-based), by End User (Hospitals & Cardiac Centers and Ambulatory Surgical Centers, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Industry Insights and Forecast to 2026 • Bio-engineered stents consist of short narrow metal or plastic tube, which is used to treat blocked arteries. It is used by patients who are suffering from different types of cardiovascular diseases such as coronary heart disease and ischemic heart disease. Different types of bio-engineered stent are available in market for various diseases such as coronary artery disease, peripheral arterial disease, carotid artery disease, renal artery stenosis, abdominal aortic aneurysm, thoracic aortic aneurysm among others.

3. Market Dynamics • Increasing prevalence of renal diseases is a major factor driving bio-engineered stents market growth. According to American Heart Association Council, in 2015, cardiovascular disease was the leading cause of death worldwide, accounting for over 17.9 million deaths annually and this number is expected to increase to over 23.6 million by 2030. According to the same source, cardiovascular diseases accounted for around 836,546 deaths in the U.S. in 2015, which accounted for around 1 in every 3 deaths. • Moreover, key players in the market are focused on adopting various strategies such as new Product Type launch and approvals and partnerships and collaborations to increase their foothold in the market. For instance, in May 2017, Medtronic plc., received the U.S. Food and Drug Administration (FDA) approval and Resolute Onyx, 4.5 MM and 5 mm sizes Drug-Eluting Stent. This device has proven clinical performance and superior deliverability of the Resolute Integrity. This device is intended to treat people with coronary artery disease in the U.S. • However, availability of alternatives for the treatment of cardiac diseases, Product Type recalls and failure, and stringent regulations for Product Type approvals are expected to hinder the market growth. For instance in November 2017, Abbott recall Class 1 Device Recall Absorb Bioresorbable Vascular Scaffold (BVS) System, an absorbable coronary drug-eluting stent due to elevated rates of major adverse events, specifically, myocardial infraction and scaffold thrombosis when compared to patients treated with the Xience metallic drug eluting stent. • Key features of the study: • This report provides in-depth analysis of the bio-engineered stents market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players • It profiles key players in the global bio-engineered stents market based on the following parameters – company overview, financial performance, Product Type portfolio, market presence, distribution strategies, key developments, strategies, and future plans • Key companies covered as a part of this study include, Medtronic, plc., Boston Scientific Corporation, Abbott Laboratories, Biotronik SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, MicroPort Scientific Corporation, Stentys Sao, Meril Life Sciences Pvt. Ltd, Vascular Concepts, W. L. Gore and Associates, C. R. Bard, Endologix, Inc., Lombard Medical Technologies, Translumina GmbH, and Jotec GmbH • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics • The global Bio-engineered stents market report caters to various stakeholders in this industry including investors, suppliers, Product Type manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the bio-engineered stents market

4. Key features of the study: • This report provides in-depth analysis of adult and pediatrichemoconcentrators market and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2018 – 2026), considering 2017, as the base year • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by leading players • It profiles leading players in the global adult and pediatrichemoconcentrators market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans • Key companies covered as a part of this study include Medivators Inc., Terumo Corporation, LivaNova, PLC, Maquet (a Getinge Group company), Medica S.p.A, and others • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics • The global adult and pediatrichemoconcentrators market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the adult and pediatrichemoconcentrators market • Detailed Segmentation: • Global Adult and Pediatric Hemoconcentrators Market, By Product Type : • Adult Hemoconcentrators • PediatricHemoconcentrators • Global Adult and Pediatric Hemoconcentrators Market, By End User: • Hospital • Ambulatory Surgical Centers • Others

5. Market Dynamics • Increasing prevalence of renal diseases is a major factor driving bio-engineered stents market growth. According to American Heart Association Council, in 2015, cardiovascular disease was the leading cause of death worldwide, accounting for over 17.9 million deaths annually and this number is expected to increase to over 23.6 million by 2030. According to the same source, cardiovascular diseases accounted for around 836,546 deaths in the U.S. in 2015, which accounted for around 1 in every 3 deaths. • Moreover, key players in the market are focused on adopting various strategies such as new Product Type launch and approvals and partnerships and collaborations to increase their foothold in the market. For instance, in May 2017, Medtronic plc., received the U.S. Food and Drug Administration (FDA) approval and Resolute Onyx, 4.5 MM and 5 mm sizes Drug-Eluting Stent. This device has proven clinical performance and superior deliverability of the Resolute Integrity. This device is intended to treat people with coronary artery disease in the U.S. • However, availability of alternatives for the treatment of cardiac diseases, Product Type recalls and failure, and stringent regulations for Product Type approvals are expected to hinder the market growth. For instance in November 2017, Abbott recall Class 1 Device Recall Absorb Bioresorbable Vascular Scaffold (BVS) System, an absorbable coronary drug-eluting stent due to elevated rates of major adverse events, specifically, myocardial infraction and scaffold thrombosis when compared to patients treated with the Xience metallic drug eluting stent. • Key features of the study: • This report provides in-depth analysis of the bio-engineered stents market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players • It profiles key players in the global bio-engineered stents market based on the following parameters – company overview, financial performance, Product Type portfolio, market presence, distribution strategies, key developments, strategies, and future plans • Key companies covered as a part of this study include, Medtronic, plc., Boston Scientific Corporation, Abbott Laboratories, Biotronik SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, MicroPort Scientific Corporation, Stentys Sao, Meril Life Sciences Pvt. Ltd, Vascular Concepts, W. L. Gore and Associates, C. R. Bard, Endologix, Inc., Lombard Medical Technologies, Translumina GmbH, and Jotec GmbH • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics • The global Bio-engineered stents market report caters to various stakeholders in this industry including investors, suppliers, Product Type manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the bio-engineered stents market

6. Global Bio-engineered Stents Market, By Geography: • North America • By Application Type: • Coronary artery disease • Peripheral arterial disease • Carotid Artery Disease • Renal Artery Stenosis • Abdominal Aortic Aneurysm • Thoracic Aortic Aneurysm • Others • By Product Type: • Drug-eluting Stents • Bioabsorbable Stents • Drug-eluting balloons • By Mode of Delivery: • Balloon-expandable Stents • Self-expanding Stents • By Material Type: • Metal-based • Polymer-based • By End User: • Hospitals & Cardiac Centers • Ambulatory Surgical Centers • Others • By Country: • U.S. • Canada • Latin America • By Application Type: • Coronary artery disease • Peripheral arterial disease • Carotid Artery Disease • Renal Artery Stenosis • Abdominal Aortic Aneurysm • Thoracic Aortic Aneurysm • Others

7. Latin America • By Product Type : • Adult Hemoconcentrators • PediatricHemoconcentrators • By End User • Hospital • Ambulatory Surgical Centers • Others • By Country: • Brazil • Mexico • Argentina • Rest of Latin America • Middle East • By Product Type : • Adult Hemoconcentrators • PediatricHemoconcentrators

8. By End User • Hospital • Ambulatory Surgical Centers • Others • By Country: • GCC • Israel • Rest of Middle East • Africa • By Product Type : • Adult Hemoconcentrators • PediatricHemoconcentrators • By End User • Hospital • Ambulatory Surgical Centers • Others • By Country/Region: • Central Africa • South Africa • North Africa • Company Profiles • Medivators Inc.* • Company Overview • Product Portfolio • Financial Performance • Key Strategies • Recent Developments • Terumo Corporation • LivaNova, PLC • Maquet (a Getinge Group company) • Medica S.p.A •  “*” marked represents similar segmentation in other categories in the respective section.

9. By Material Type: • Metallic • Polymer • PLGA- Poly lactic-co-glycolic acid • PLLA- Poly L-lactide • PGA- Polyglycolic Acid • PLA- Polylactic Acid • Others • By Application: • Orthopedic • Cardiovascular • Others • By End User: • Hospitals • Ambulatory Surgical Centers • Others • Ambulatory Surgical Centers • Specialty Clinics • By Country: • GCC • Israel • Rest of Middle East • Africa

10. By Material Type: • Metallic • Polymer • PLGA- Poly lactic-co-glycolic acid • PLLA- Poly L-lactide • PGA- Polyglycolic Acid • PLA- Polylactic Acid • Others • By Application: • Orthopedic • Cardiovascular • Others • By End User: • Hospitals • Ambulatory Surgical Centers • Others • By Country: • South Africa • Central Africa • North Africa

11. Company Profiles • Bioretec Ltd. * • Company Overview • Product Portfolio • Financial Performance • Key Highlights • Market Strategies • CONMED Corporation • Depuy Synthes • Stryker Corporation • Smith & Nephew Plc. • Zimmer Biomet Holdings Inc. • Boston Scientific Corporation •  “*” marked represents similar segmentation in other categories in the respective section.

12. Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst • Buy Now • Reference: • https://www.coherentmarketinsights.com/market-insight/bio-engineered-stent-market-2484

13. About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

14. Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

15. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/